Two-year outcome of intravitreal aflibercept injection in vitrectomized eyes with diabetic macular edema

0 avis

Two-year outcome of intravitreal aflibercept injection in vitrectomized eyes with diabetic macular edema

Archive ouverte : Article de revue

Edité par HAL CCSD ; Association for Research in Vision and Ophthalmology

International audience

Langue: Anglais

Date de publication: 2022

Source: ISSN: 0146-0404

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Impact of neovascular age-related macular degeneration on eye-movement cont...

Archive ouverte: Article de revue

Thibaut, Miguel | 2022-12

International audience

Impact of neovascular age-related macular degeneration on eye-movement cont...

Archive ouverte: Article de revue

Nuthmann, Antje | 2022

International audience. Human vision requires us to analyze the visual periphery to decide where to fixate next. In the present study, we investigated this process in people with age-related macular degeneration (AM...

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eye...

Archive ouverte: Article de revue

Tran, Thi Ha Chau | 2022

Purpose: To evaluate the efficacy of intravitreal aflibercept injection (IAI) for vitrectomized eyes with diabetic macular edema (DME) at two years.Methods: This is a prospective, non-comparative, multicenter observational study i...

Chargement des enrichissements...